Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating VX-150 for pain due to small fiber neuropathy has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Fiber Neuropathy

Drugs mentioned

• VX-150

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Small Fiber Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2021-11-15